Lista de obras -

Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study

artículo científico publicado en 2008

Caveolin-1 Expression in Upper Tract Urothelial Carcinoma

artículo científico publicado en 2017

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence

artículo científico publicado en 2007

Features and outcomes of patients with grade IV renal injury

artículo científico publicado en 2008

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

artículo científico publicado en 2016

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers

artículo científico publicado en 2008

Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma

artículo científico publicado en 2013

Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications

scientific article published on 17 September 2020

New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

artículo científico publicado en 2007

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy

artículo científico publicado en 2020

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer

artículo científico publicado en 2006

Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer

scientific article published on 01 September 2007

Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy

artículo científico publicado en 2008

Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent

artículo científico publicado en 2015

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

artículo científico publicado en 2016

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study

artículo científico publicado en 2016

Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.

artículo científico

Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy

artículo científico publicado en 2016

Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial

artículo científico publicado en 2015

Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma

artículo científico publicado en 2008

Survival Following Cytoreductive Nephrectomy: A Comparison of Existing Prognostic Models

artículo científico publicado en 2020

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study

artículo científico publicado en 2009

Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study

artículo científico publicado en 2015

The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.

artículo científico publicado en 2017

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy

scientific article published on 08 September 2018

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

artículo científico publicado en 2007

Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer

artículo científico publicado en 2008

Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG,

artículo científico publicado en 2009

Lista de obras de

Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study

Caveolin-1 Expression in Upper Tract Urothelial Carcinoma

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence

Features and outcomes of patients with grade IV renal injury

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers

Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma

Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications

New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer

Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer

Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy

Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study

Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.

Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy

Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial

Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma

Survival Following Cytoreductive Nephrectomy: A Comparison of Existing Prognostic Models

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study

Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study

The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer

Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG,

p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy